Joseph C Pelletier, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 44 S Main St, Randolph, VT 05060 Phone: 802-728-2420 Fax: 802-728-2394 |
Devin Alexander, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 44 S Main St, Randolph, VT 05060 Phone: 802-728-2420 |
Louis A. Dinicola, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 44 S Main St, Randolph, VT 05060 Phone: 802-728-2420 Fax: 802-728-2613 |
Elizabeth H. Jewett, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 44 S Main St, Randolph, VT 05060 Phone: 802-728-2420 Fax: 802-728-2613 |
News Archive
A novel single-pill combination drug could present a new treatment option for patients with the most difficult-to-treat forms of hepatitis C, according to the results of a Phase 2 trial, published in The Lancet.
Selecta Biosciences, Inc., a biopharmaceutical company developing an entirely new class of targeted vaccines and immunotherapies, today announced that Science Applications International Corporation (SAIC) has awarded Selecta a subcontract to develop a targeted synthetic vaccine particle product for malaria.
President Barack Obama seems to be losing the battle to include in the jobs bill - also known as the "extender" bill - a continuation of federal subsidies for laid-off workers to help pay for health insurance through COBRA, The Associated Press reports. Sens. Bob Casey, D-Pa., and Sherrod Brown, D-Ohio, "who are seeking a vote this coming week, want to attach their nearly $7 billion provision to must-pass legislation that would extend unemployment benefits and make changes in dozens of federal programs.
The same immune system that fights infection and the flu could join the battle against opioid addiction, new research out of the Vanderbilt Center for Addiction Research indicates.
Kimberly-Clark Corporation and I-Flow Corporation, a leading healthcare company that develops and markets technically advanced, low-cost drug delivery systems and innovative products for post-surgical pain relief and surgical site care, today announced a definitive agreement whereby I-Flow will be acquired in a cash tender offer for approximately $324 million on a fully diluted basis.
› Verified 8 days ago